These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 3145201
21. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
22. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42). Cauvin A, Vandermeers A, Vandermeers-Piret MC, Robberecht P, Christophe J. Endocrinology; 1989 Nov; 125(5):2645-55. PubMed ID: 2792003 [Abstract] [Full Text] [Related]
23. An improved method to obtain a single recombinant vasoactive intestinal peptide (VIP) analog. Ottavi A, Tiennault E, Maftah A, Berjeaud JM, Cenatiempo Y, Julien R. Biochimie; 1998 Apr; 80(4):289-93. PubMed ID: 9672747 [Abstract] [Full Text] [Related]
24. Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: comparison with rat intestinal receptors. Laburthe M, Couvineau A, Rouyer-Fessard C, Moroder L. Life Sci; 1985 Mar 11; 36(10):991-5. PubMed ID: 2983161 [Abstract] [Full Text] [Related]
25. Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion. You S, Silsby JL, Farris J, Foster DN, el Halawani ME. Endocrinology; 1995 Jun 11; 136(6):2602-10. PubMed ID: 7750483 [Abstract] [Full Text] [Related]
26. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M. Mol Pharmacol; 1996 Dec 11; 50(6):1596-604. PubMed ID: 8967982 [Abstract] [Full Text] [Related]
27. Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Mourad FH, Nassar CF. Gut; 2000 Sep 11; 47(3):382-6. PubMed ID: 10940276 [Abstract] [Full Text] [Related]
28. Expression of honeybee prepromelittin as a fusion protein in Escherichia coli. He M, Adcock I, Chapman D, Lucy J, Austen B. Protein Expr Purif; 1991 Sep 11; 2(5-6):363-71. PubMed ID: 1821810 [Abstract] [Full Text] [Related]
29. Rat PHI, PHI-GLY and PHV (1-42) stimulate adenylate cyclase in six rat tissue and cell membranes. Cauvin A, Vandermeers-Piret MC, Vandermeers A, Coussaert E, de Neef P, Robberecht P, Christophe J. Peptides; 1990 Sep 11; 11(5):1009-14. PubMed ID: 2178243 [Abstract] [Full Text] [Related]
30. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Neuron; 1992 Apr 11; 8(4):811-9. PubMed ID: 1314625 [Abstract] [Full Text] [Related]
31. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Dvoráková MC, Pfeil U, Kuncová J, Svíglerová J, Galvis G, Krasteva G, König P, Grau V, Slavíková J, Kummer W. Cell Tissue Res; 2006 Mar 11; 323(3):383-93. PubMed ID: 16344947 [Abstract] [Full Text] [Related]
32. Expression of prepro-VIP derived peptides in the gastrointestinal tract of normal, hypothyroid and hyperthyroid rats. Buhl T, Nilsson C, Ekblad E, Johnsen AH, Fahrenkrug J. Neuropeptides; 1996 Jun 11; 30(3):237-47. PubMed ID: 8819148 [Abstract] [Full Text] [Related]
33. Detection of vasoactive intestinal peptide-encoding messenger ribonucleic acid in the rat ovaries. Gozes I, Tsafriri A. Endocrinology; 1986 Dec 11; 119(6):2606-10. PubMed ID: 3780542 [Abstract] [Full Text] [Related]
34. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion. Inagaki N, Kuromi H, Seino S. Ann N Y Acad Sci; 1996 Dec 26; 805():44-51; discussion 52-3. PubMed ID: 8993392 [Abstract] [Full Text] [Related]
35. All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen. Skakkebaek ML, Georg B, Mikkelsen JD, Ottesen B, Fahrenkrug J. Peptides; 1995 Dec 26; 16(7):1287-94. PubMed ID: 8545253 [Abstract] [Full Text] [Related]
36. Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats. Gozes I, Shani Y. Endocrinology; 1986 Dec 26; 119(6):2497-501. PubMed ID: 3780537 [Abstract] [Full Text] [Related]
37. Cloning and expression of the human vasoactive intestinal peptide receptor. Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ. Proc Natl Acad Sci U S A; 1991 Jun 01; 88(11):4986-90. PubMed ID: 1675791 [Abstract] [Full Text] [Related]
38. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R. Reproduction; 2007 Aug 01; 134(2):281-92. PubMed ID: 17660238 [Abstract] [Full Text] [Related]
39. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors. Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018 [Abstract] [Full Text] [Related]
40. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ. J Mol Neurosci; 2005 Dec 11; 25(3):215-24. PubMed ID: 15800375 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]